86.21.Z - General medical practice activities
21.20.Z - Manufacture of medicines and other pharmaceutical products
46.46.Z - Wholesale of pharmaceutical goods
46.90.Z - Non-specialised wholesale trade
47.73.Z - Dispensing chemist in specialised stores
47.74.Z - Retail sale of medical and orthopaedic goods in specialised stores
85.59.B - Other out-of-school forms of education, not elsewhere classified
86.22.Z - Specialist medical practice activities
86.90.E - Other human health activities notelsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0 | 0 | 0 | -62,1 |
EBITDA | 0 | 0 | 0 | -22,1 |
Short time liabilities | 0,2 | 0,2 | 0,5 | 83,9 |
Equity capital | 1,3 | 1,3 | 1,3 | 0,2 |
Operating profit (EBIT) | 0 | 0 | 0 | -61,8 |
Assets | 1,5 | 1,6 | 1,8 | 13,1 |
Net profit (loss) | -0 | 0 | 0 | -71,3 |
Cash | 0,7 | 0,8 | 0,9 | 11 |
Net income from sale | 2,7 | 2,7 | 3 | 12,1 |
Liabilities and provisions for liabilities | 0,2 | 0,3 | 0,5 | 78,8 |
Working assets | 0,9 | 1,1 | 1,2 | 15,2 |
Depreciation | 0 | 0 | 0 | 6,2 |
% | % | % | p.p. | |
Profitability of capital | -0 | 0,8 | 0,2 | -0,6 |
Equity capital to total assets | 87,9 | 83,6 | 74,1 | -9,5 |
Gross profit margin | 0,1 | 0,6 | 0,2 | -0,4 |
EBITDA Margin | 1,5 | 1,5 | 1 | -0,5 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 23 | 34 | 56 | 22 |
Current financial liquidity indicator | 5.179471492767334 | 4.05472469329834 | 2.6119046211242676 | -1,5 |
Net dept to EBITDA | -17.055784225463867 | -20.236812591552734 | -28.825366973876953 | -8,6 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane